Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	extracellular matrix constituent, lubricant activity	MUC17 MUC3A MUC4	4.27e-08	4	45	3	GO:0030197
GeneOntologyMolecularFunction	aryl hydrocarbon receptor binding	NCOA2 TAF6	1.77e-04	9	45	2	GO:0017162
GeneOntologyMolecularFunction	mismatch repair complex binding	MLH1 PCNA	2.70e-04	11	45	2	GO:0032404
GeneOntologyMolecularFunction	mismatched DNA binding	MLH1 PCNA	4.44e-04	14	45	2	GO:0030983
GeneOntologyMolecularFunction	DNA polymerase binding	NCOA2 PCNA	1.22e-03	23	45	2	GO:0070182
GeneOntologyMolecularFunction	structural constituent of nuclear pore	POM121L2 NPAP1	1.44e-03	25	45	2	GO:0017056
GeneOntologyMolecularFunction	nuclear localization sequence binding	POM121L2 NPAP1	1.68e-03	27	45	2	GO:0008139
GeneOntologyMolecularFunction	DNA-binding transcription factor binding	NCOA2 KMT2A TBX3 TAF6 MED13 PCNA	1.85e-03	582	45	6	GO:0140297
GeneOntologyBiologicalProcess	ureteric peristalsis	TBX3 TSHZ3	1.33e-05	3	44	2	GO:0072105
GeneOntologyBiologicalProcess	ureter smooth muscle contraction	TBX3 TSHZ3	1.33e-05	3	44	2	GO:0014849
GeneOntologyBiologicalProcess	mammary placode formation	TBX3 NRG3	2.66e-05	4	44	2	GO:0060596
GeneOntologyCellularComponent	Golgi lumen	MUC19 MUC16 MUC5B MUC3B MUC17 MUC3A MUC4	4.57e-09	109	47	7	GO:0005796
GeneOntologyCellularComponent	MLL1 complex	KMT2A TAF6 MGA	5.05e-05	32	47	3	GO:0071339
GeneOntologyCellularComponent	MLL1/2 complex	KMT2A TAF6 MGA	5.54e-05	33	47	3	GO:0044665
GeneOntologyCellularComponent	cyclin-dependent protein kinase holoenzyme complex	CCNB3 MED13 PCNA	3.50e-04	61	47	3	GO:0000307
GeneOntologyCellularComponent	histone methyltransferase complex	KMT2A TAF6 MGA	6.42e-04	75	47	3	GO:0035097
GeneOntologyCellularComponent	nuclear protein-containing complex	NCOA2 MLH1 KMT2A POM121L2 ATF1 TAF6 MGA MED13 PCNA NPAP1	8.18e-04	1377	47	10	GO:0140513
HumanPheno	Thin vermilion border	SCYL2 KMT2A NBAS HUWE1 TAF6 MED13 NPAP1	1.66e-05	433	12	7	HP:0000233
Domain	SEA	MUC16 MUC3B MUC17 MUC3A	2.64e-08	14	44	4	SM00200
Domain	VWD	MUC19 MUC5B ZAN MUC4	4.78e-08	16	44	4	SM00216
Domain	VWF_type-D	MUC19 MUC5B ZAN MUC4	4.78e-08	16	44	4	IPR001846
Domain	VWFD	MUC19 MUC5B ZAN MUC4	4.78e-08	16	44	4	PS51233
Domain	VWD	MUC19 MUC5B ZAN MUC4	4.78e-08	16	44	4	PF00094
Domain	SEA	MUC16 MUC3B MUC17 MUC3A	2.30e-07	23	44	4	PS50024
Domain	SEA_dom	MUC16 MUC3B MUC17 MUC3A	2.30e-07	23	44	4	IPR000082
Domain	EGF_3	MUC3B NRG3 ZAN MUC17 MUC3A MUC4 LRP8	1.18e-06	235	44	7	PS50026
Domain	EGF	MUC3B NRG3 ZAN MUC17 MUC3A MUC4 LRP8	1.18e-06	235	44	7	SM00181
Domain	EGF-like_dom	MUC3B NRG3 ZAN MUC17 MUC3A MUC4 LRP8	1.73e-06	249	44	7	IPR000742
Domain	EGF_1	MUC3B NRG3 ZAN MUC17 MUC3A MUC4 LRP8	2.03e-06	255	44	7	PS00022
Domain	EGF-like_CS	MUC3B NRG3 ZAN MUC17 MUC3A MUC4 LRP8	2.37e-06	261	44	7	IPR013032
Domain	EGF_2	MUC3B NRG3 ZAN MUC17 MUC3A MUC4 LRP8	2.62e-06	265	44	7	PS01186
Domain	TIL	MUC19 MUC5B ZAN	2.64e-06	12	44	3	PF01826
Domain	C8	MUC19 MUC5B ZAN	2.64e-06	12	44	3	PF08742
Domain	Unchr_dom_Cys-rich	MUC19 MUC5B ZAN	3.43e-06	13	44	3	IPR014853
Domain	C8	MUC19 MUC5B ZAN	3.43e-06	13	44	3	SM00832
Domain	TIL_dom	MUC19 MUC5B ZAN	4.36e-06	14	44	3	IPR002919
Domain	VWC_out	MUC19 MUC5B ZAN	1.15e-05	19	44	3	SM00215
Domain	SEA	MUC16 MUC3B MUC17	1.82e-05	22	44	3	PF01390
Domain	VWC	MUC19 MUC5B ZAN	9.71e-05	38	44	3	SM00214
Domain	VWFC_2	MUC19 MUC5B ZAN	9.71e-05	38	44	3	PS50184
Domain	VWF_dom	MUC19 MUC5B ZAN	1.31e-04	42	44	3	IPR001007
Domain	EGF	NRG3 ZAN MUC4 LRP8	2.18e-04	126	44	4	PF00008
Domain	-	MUC16 MUC17	5.59e-04	15	44	2	3.30.70.960
Domain	TF_T-box	TBX3 MGA	7.21e-04	17	44	2	IPR001699
Domain	TBOX	TBX3 MGA	7.21e-04	17	44	2	SM00425
Domain	TF_T-box_CS	TBX3 MGA	7.21e-04	17	44	2	IPR018186
Domain	-	TBX3 MGA	7.21e-04	17	44	2	2.60.40.820
Domain	TBOX_3	TBX3 MGA	7.21e-04	17	44	2	PS50252
Domain	T-box	TBX3 MGA	7.21e-04	17	44	2	PF00907
Domain	TBOX_1	TBX3 MGA	7.21e-04	17	44	2	PS01283
Domain	TBOX_2	TBX3 MGA	7.21e-04	17	44	2	PS01264
Domain	CTCK_1	MUC19 MUC5B	8.10e-04	18	44	2	PS01185
Domain	ARM-type_fold	SCYL2 HUWE1 TAF6 HECTD1 MAP3K1	1.16e-03	339	44	5	IPR016024
Domain	CT	MUC19 MUC5B	1.22e-03	22	44	2	SM00041
Domain	Cys_knot_C	MUC19 MUC5B	1.57e-03	25	44	2	IPR006207
Domain	CTCK_2	MUC19 MUC5B	1.57e-03	25	44	2	PS01225
Domain	HECT	HUWE1 HECTD1	1.83e-03	27	44	2	PF00632
Domain	HECTc	HUWE1 HECTD1	1.83e-03	27	44	2	SM00119
Domain	HECT_dom	HUWE1 HECTD1	1.83e-03	27	44	2	IPR000569
Domain	HECT	HUWE1 HECTD1	1.83e-03	27	44	2	PS50237
Domain	VWFC_1	MUC5B ZAN	3.25e-03	36	44	2	PS01208
Domain	ARM-like	SCYL2 HUWE1 TAF6 HECTD1	3.68e-03	270	44	4	IPR011989
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC16 MUC5B MUC17 MUC3A MUC4	4.63e-10	16	38	5	M27410
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC16 MUC5B MUC17 MUC3A MUC4	6.54e-10	17	38	5	M27412
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC19 MUC16 MUC5B MUC17 MUC4	2.14e-09	21	38	5	MM15706
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC16 MUC5B MUC17 MUC3A MUC4	3.52e-09	23	38	5	M556
Pathway	REACTOME_DECTIN_2_FAMILY	MUC16 MUC5B MUC17 MUC3A MUC4	6.84e-09	26	38	5	M27483
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC19 MUC16 MUC5B MUC17 MUC4	5.31e-07	60	38	5	MM15636
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC16 MUC5B MUC17 MUC3A MUC4	6.27e-07	62	38	5	M546
Pathway	REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS	MUC16 MUC5B MUC17 MUC3A MUC4	9.98e-07	68	38	5	M27303
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	MUC19 MUC16 MUC5B MUC17 MUC4	1.03e-05	109	38	5	MM15164
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	MUC16 MUC5B MUC17 MUC3A MUC4	1.13e-05	111	38	5	M27416
Pathway	REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS	MUC16 MUC5B MUC17 MUC3A MUC4	3.47e-05	140	38	5	M27484
Pathway	REACTOME_DISEASES_OF_GLYCOSYLATION	MUC16 MUC5B MUC17 MUC3A MUC4	3.84e-05	143	38	5	M27275
Pathway	WP_OXIDATIVE_DAMAGE_RESPONSE	OPRPN MAP3K1 PCNA	1.93e-04	42	38	3	MM15945
Pathway	WP_MISMATCH_REPAIR	MLH1 PCNA	2.52e-04	9	38	2	MM15932
Pathway	REACTOME_DISEASES_OF_METABOLISM	MUC16 MUC5B MUC17 MUC3A MUC4	5.24e-04	250	38	5	M27554
Pathway	REACTOME_INNATE_IMMUNE_SYSTEM	MUC16 MUC5B ATF1 HUWE1 DSC1 MUC17 MUC3A MUC4 CD300A MAP3K1	6.14e-04	1128	38	10	M1036
Pathway	REACTOME_MISMATCH_REPAIR	MLH1 PCNA	7.27e-04	15	38	2	M27442
Pathway	REACTOME_MISMATCH_REPAIR	MLH1 PCNA	7.27e-04	15	38	2	MM15184
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC19 MUC16 MUC5B MUC17 MUC3A MUC4	9.16e-14	18	48	6	18834073
Pubmed	Genomic organization and structure of the 3' region of human MUC3: alternative splicing predicts membrane-bound and soluble forms of the mucin.	MUC3B MUC17 MUC3A	2.47e-09	3	48	3	10512748
Pubmed	Expression of Muc19/Smgc gene products during murine sublingual gland development: cytodifferentiation and maturation of salivary mucous cells.	MUC19 MUC16 MUC5B	4.92e-08	6	48	3	19110483
Pubmed	Initiation of transcription of the MUC3A human intestinal mucin from a TATA-less promoter and comparison with the MUC3B amino terminus.	MUC3B MUC3A	1.87e-06	2	48	2	12958310
Pubmed	The beta sliding clamp binds to multiple sites within MutL and MutS.	MLH1 PCNA	1.87e-06	2	48	2	16546997
Pubmed	Multiple transcripts of MUC3: evidence for two genes, MUC3A and MUC3B.	MUC3B MUC3A	1.87e-06	2	48	2	10973822
Pubmed	MUC3 human intestinal mucin. Analysis of gene structure, the carboxyl terminus, and a novel upstream repetitive region.	MUC3B MUC3A	1.87e-06	2	48	2	9334251
Pubmed	Molecular cloning of cDNAs derived from a novel human intestinal mucin gene.	MUC3B MUC3A	1.87e-06	2	48	2	2393399
Pubmed	Associations of distinct variants of the intestinal mucin gene MUC3A with ulcerative colitis and Crohn's disease.	MUC3B MUC3A	1.87e-06	2	48	2	11289722
Pubmed	Immunocytochemistry for MUC4 and MUC16 is a useful adjunct in the diagnosis of pancreatic adenocarcinoma on fine-needle aspiration cytology.	MUC16 MUC4	1.87e-06	2	48	2	23544943
Pubmed	Expression of mucins in mucoid otitis media.	MUC5B MUC4	1.87e-06	2	48	2	14690056
Pubmed	The MUC3 gene encodes a transmembrane mucin and is alternatively spliced.	MUC3B MUC3A	1.87e-06	2	48	2	10405327
Pubmed	Regulation of oxidative DNA damage repair by DNA polymerase λ and MutYH by cross-talk of phosphorylation and ubiquitination.	HUWE1 PCNA	5.59e-06	3	48	2	22203964
Pubmed	Microbial products alter the expression of membrane-associated mucin and antimicrobial peptides in a three-dimensional human endocervical epithelial cell model.	MUC16 MUC4	5.59e-06	3	48	2	23053434
Pubmed	Expression of mucin (MUC) genes in mucoepidermoid carcinoma.	MUC19 MUC4	5.59e-06	3	48	2	21072847
Pubmed	DUSP28 links regulation of Mucin 5B and Mucin 16 to migration and survival of AsPC-1 human pancreatic cancer cells.	MUC16 MUC5B	5.59e-06	3	48	2	27230679
Pubmed	Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas.	MUC16 MUC4	5.59e-06	3	48	2	30236127
Pubmed	Expression of mucin 3 and mucin 5AC in arthritic synovial tissue.	MUC3B MUC3A	5.59e-06	3	48	2	18163520
Pubmed	Interaction of proliferating cell nuclear antigen with PMS2 is required for MutLα activation and function in mismatch repair.	MLH1 PCNA	5.59e-06	3	48	2	28439008
Pubmed	Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone.	MUC16 MUC4	5.59e-06	3	48	2	17592322
Pubmed	Two atypical enteropathogenic Escherichia coli strains induce the production of secreted and membrane-bound mucins to benefit their own growth at the apical surface of human mucin-secreting intestinal HT29-MTX cells.	MUC17 MUC4	5.59e-06	3	48	2	20065027
Pubmed	Recurrent YAP1 and KMT2A Gene Rearrangements in a Subset of MUC4-negative Sclerosing Epithelioid Fibrosarcoma.	KMT2A MUC4	5.59e-06	3	48	2	31592798
Pubmed	Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection.	MUC16 MUC4	5.59e-06	3	48	2	35879412
Pubmed	Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling).	MUC16 MUC4	5.59e-06	3	48	2	27483328
Pubmed	MicroRNA-200c modulates the expression of MUC4 and MUC16 by directly targeting their coding sequences in human pancreatic cancer.	MUC16 MUC4	5.59e-06	3	48	2	24204560
Pubmed	Expression of the transmembrane mucins, MUC1, MUC4 and MUC16, in normal endometrium and in endometriosis.	MUC16 MUC4	5.59e-06	3	48	2	24939955
Pubmed	Whole exome sequencing identifies MAP3K1, MSH2, and MLH1 as potential cancer-predisposing genes in familial early-onset colorectal cancer.	MLH1 MAP3K1	5.59e-06	3	48	2	37314251
Pubmed	Interaction network of human early embryonic transcription factors.	NCOA2 KMT2A TBX3 TSHZ3 MGA EMSY	8.69e-06	351	48	6	38297188
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	SCYL2 NCOA2 KMT2A HUWE1 TAF6 MGA EMSY	9.88e-06	549	48	7	38280479
Pubmed	Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF.	KMT2A TAF6 MGA	1.08e-05	31	48	3	15960975
Pubmed	FAN1 interaction with ubiquitylated PCNA alleviates replication stress and preserves genomic integrity independently of BRCA2.	MLH1 PCNA	1.12e-05	4	48	2	29051491
Pubmed	Secalonic acid D alters the expression and phosphorylation of the transcription factors and their binding to cAMP response element in developing murine secondary palate.	ATF1 PCNA	1.12e-05	4	48	2	11354513
Pubmed	HUWE1 interacts with PCNA to alleviate replication stress.	HUWE1 PCNA	1.12e-05	4	48	2	27146073
Pubmed	Nuclear reorganization of DNA mismatch repair proteins in response to DNA damage.	MLH1 PCNA	1.12e-05	4	48	2	20004149
Pubmed	TRPV4 activation in human corneal epithelial cells promotes membrane mucin production.	MUC16 MUC4	1.12e-05	4	48	2	39024979
Pubmed	Butyrate enemas upregulate Muc genes expression but decrease adherent mucus thickness in mice colon.	MUC17 MUC4	1.12e-05	4	48	2	18198997
Pubmed	Genetic variation in genes interacting with BRCA1/2 and risk of breast cancer in the Cypriot population.	MLH1 ATF1 PCNA	1.31e-05	33	48	3	19714462
Pubmed	Polymorphism of human mucin genes in chest disease: possible significance of MUC2.	MUC5B MUC4	1.86e-05	5	48	2	11062147
Pubmed	PCNA activates the MutLγ endonuclease to promote meiotic crossing over.	MLH1 PCNA	1.86e-05	5	48	2	32814343
Pubmed	Multifaceted transcriptional regulation of the murine intestinal mucus layer by endogenous microbiota.	MUC17 MUC4	1.86e-05	5	48	2	18035521
Pubmed	Activity-Based Probes for HECT E3 Ubiquitin Ligases.	HUWE1 HECTD1	1.86e-05	5	48	2	28425671
Pubmed	Characterization of human exonuclease 1 in complex with mismatch repair proteins, subcellular localization and association with PCNA.	MLH1 PCNA	1.86e-05	5	48	2	14676842
Pubmed	A novel mechanism of G protein-dependent phosphorylation of vasodilator-stimulated phosphoprotein.	VASP MAP3K1	1.86e-05	5	48	2	16046415
Pubmed	Genomic instability in mice lacking histone H2AX.	MLH1 PCNA	2.79e-05	6	48	2	11934988
Pubmed	Regulation of the MLH1-MLH3 endonuclease in meiosis.	MLH1 PCNA	2.79e-05	6	48	2	32814904
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	NCOA2 TBX3 TAF6 MGA EMSY PCNA	3.26e-05	444	48	6	34795231
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	NCOA2 KMT2A MGA MED13 EMSY	3.42e-05	268	48	5	33640491
Pubmed	Identification of the scaramanga gene implicates Neuregulin3 in mammary gland specification.	TBX3 NRG3	3.90e-05	7	48	2	16140987
Pubmed	A defined human system that supports bidirectional mismatch-provoked excision.	MLH1 PCNA	3.90e-05	7	48	2	15225546
Pubmed	Induced alpha-helix structure in the aryl hydrocarbon receptor transactivation domain modulates protein-protein interactions.	NCOA2 TAF6	3.90e-05	7	48	2	15641800
Pubmed	Targeted disruption of exons 1 to 6 of the Fanconi Anemia group A gene leads to growth retardation, strain-specific microphthalmia, meiotic defects and primordial germ cell hypoplasia.	MLH1 PCNA	3.90e-05	7	48	2	12913077
Pubmed	GATA-Binding Factor 6 Contributes to Atrioventricular Node Development and Function.	TBX3 PCNA	5.19e-05	8	48	2	25613430
Pubmed	An Oct4-centered protein interaction network in embryonic stem cells.	TAF6 MGA MED13 EMSY	8.46e-05	167	48	4	20362541
Pubmed	Lineage and morphogenetic analysis of the cardiac valves.	TBX3 PCNA	1.02e-04	11	48	2	15297379
Pubmed	Mammalian BTBD12 (SLX4) protects against genomic instability during mammalian spermatogenesis.	MLH1 PCNA	1.22e-04	12	48	2	21655083
Pubmed	Generation and comprehensive analysis of an influenza virus polymerase cellular interaction network.	TAF6 PCNA	1.22e-04	12	48	2	21994455
Pubmed	NCOA2 promotes lytic reactivation of Kaposi's sarcoma-associated herpesvirus by enhancing the expression of the master switch protein RTA.	NCOA2 HECTD1 PCNA	1.27e-04	70	48	3	31751430
Pubmed	The deubiquitinase USP9X regulates FBW7 stability and suppresses colorectal cancer.	KMT2A HUWE1 HECTD1	1.32e-04	71	48	3	29346117
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	TBX3 ATF1 HUWE1 VASP LRP8	1.34e-04	358	48	5	32460013
Pubmed	Diminished pancreatic beta-cell mass in securin-null mice is caused by beta-cell apoptosis and senescence.	MLH1 PCNA	1.44e-04	13	48	2	19213844
Pubmed	DNA repair protein FANCD2 has both ubiquitination-dependent and ubiquitination-independent functions during germ cell development.	MLH1 PCNA	1.44e-04	13	48	2	36642183
Pubmed	Identification of KIAA1018/FAN1, a DNA repair nuclease recruited to DNA damage by monoubiquitinated FANCD2.	MLH1 PCNA	1.94e-04	15	48	2	20603015
Pubmed	Ectodysplasin/NF-κB Promotes Mammary Cell Fate via Wnt/β-catenin Pathway.	TBX3 NRG3	2.21e-04	16	48	2	26581094
Pubmed	LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells.	KMT2A HUWE1 DSC1 HECTD1 VASP PCNA	2.39e-04	639	48	6	23443559
Pubmed	Teashirt 3 is necessary for ureteral smooth muscle differentiation downstream of SHH and BMP4.	TSHZ3 PCNA	2.50e-04	17	48	2	18776146
Pubmed	Genetic determinants of P wave duration and PR segment.	TBX3 MED13	2.50e-04	17	48	2	24850809
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	SCYL2 MLH1 KMT2A TAF6 DSC1 EMSY PCNA	2.78e-04	934	48	7	33916271
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	MLH1 TBX3 HUWE1 MGA HECTD1 VASP MED13 PCNA	2.81e-04	1247	48	8	27684187
Pubmed	DVC1 (C1orf124) is a DNA damage-targeting p97 adaptor that promotes ubiquitin-dependent responses to replication blocks.	MLH1 PCNA	2.81e-04	18	48	2	23042605
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	TSHZ3 MGA VASP MAP3K1 STON2	3.12e-04	430	48	5	35044719
Pubmed	Haploinsufficiency of SAMD9L, an endosome fusion facilitator, causes myeloid malignancies in mice mimicking human diseases with monosomy 7.	MUC19 MUC4 STON2	3.12e-04	95	48	3	24029230
Pubmed	An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis.	KMT2A MED13	3.14e-04	19	48	2	16799563
Pubmed	STAGA recruits Mediator to the MYC oncoprotein to stimulate transcription and cell proliferation.	TAF6 MED13	3.49e-04	20	48	2	17967894
Pubmed	ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation.	KMT2A TAF6	3.85e-04	21	48	2	12453419
Pubmed	NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.	KMT2A TSHZ3 TAF6	3.96e-04	103	48	3	32744500
Pubmed	Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	TRAK2 MGA MED13	4.19e-04	105	48	3	9628581
Pubmed	A mouse knockout library for secreted and transmembrane proteins.	MUC16 HAVCR1 SCPEP1 TMEM123 CD300A	4.25e-04	460	48	5	20562862
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	KMT2A NBAS TAF6 MGA HECTD1 MED13 EMSY NPAP1	4.26e-04	1327	48	8	32694731
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	KMT2A HUWE1 USP42 MUC4 PCNA	4.64e-04	469	48	5	27634302
Pubmed	E-cadherin is required for intestinal morphogenesis in the mouse.	MUC17 MUC4	5.05e-04	24	48	2	22766025
Pubmed	Single nucleotide polymorphisms in miRNA binding sites and miRNA genes as breast/ovarian cancer risk modifiers in Jewish high-risk women.	ATF1 PCNA	5.05e-04	24	48	2	19950226
Pubmed	The human CDK8 subcomplex is a molecular switch that controls Mediator coactivator function.	TAF6 MED13	5.48e-04	25	48	2	19240132
Pubmed	System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes.	HUWE1 HECTD1	5.93e-04	26	48	2	26949039
Pubmed	Bmp2 and Notch cooperate to pattern the embryonic endocardium.	TBX3 PCNA	5.93e-04	26	48	2	29853617
Pubmed	MRNIP interacts with sex body chromatin to support meiotic progression, spermatogenesis, and male fertility in mice.	MLH1 PCNA	5.93e-04	26	48	2	35920200
Pubmed	CEP63 deficiency promotes p53-dependent microcephaly and reveals a role for the centrosome in meiotic recombination.	MLH1 PCNA	6.40e-04	27	48	2	26158450
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	KMT2A HUWE1 TAF6 USP42 MED13 EMSY	6.60e-04	774	48	6	15302935
Pubmed	Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers.	TAF6 MGA EMSY	6.80e-04	124	48	3	20850016
Pubmed	Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease.	MUC19 EMSY	6.89e-04	28	48	2	18587394
Pubmed	Human transcription factor protein interaction networks.	NCOA2 KMT2A TSHZ3 ATF1 TAF6 MGA EMSY PCNA	6.94e-04	1429	48	8	35140242
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	TRAK2 HECTD1 OMG EMSY PCNA	6.95e-04	513	48	5	25798074
Pubmed	Evidence for significant overlap between common risk variants for Crohn's disease and ankylosing spondylitis.	MUC19 EMSY	8.45e-04	31	48	2	21072187
Pubmed	Tbx3 controls the sinoatrial node gene program and imposes pacemaker function on the atria.	TBX3 PCNA	8.45e-04	31	48	2	17473172
Pubmed	BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors.	MLH1 KMT2A MGA	8.52e-04	134	48	3	25452129
Pubmed	Molecular mapping of developing dorsal horn-enriched genes by microarray and dorsal/ventral subtractive screening.	TSHZ3 AJAP1	9.01e-04	32	48	2	16516881
Pubmed	Tbx3 controls the fate of hepatic progenitor cells in liver development by suppressing p19ARF expression.	TBX3 PCNA	9.58e-04	33	48	2	18356246
Pubmed	Hepatocyte nuclear factor 4alpha is essential for embryonic development of the mouse colon.	MUC17 MUC4	9.58e-04	33	48	2	16618389
Pubmed	The E3 ubiquitin ligases, HUWE1 and NEDD4-1, are involved in the post-translational regulation of the ABCG1 and ABCG4 lipid transporters.	HUWE1 HECTD1	9.58e-04	33	48	2	26296893
Pubmed	Genome-wide contribution of genotype by environment interaction to variation of diabetes-related traits.	NRG3 MAP3K1	9.58e-04	33	48	2	24204828
Pubmed	The splicing regulator Rbfox2 is required for both cerebellar development and mature motor function.	HUWE1 LRP8	9.58e-04	33	48	2	22357600
Interaction	FEV interactions	NCOA2 KMT2A ATF1 TAF6 MGA EMSY	5.70e-06	203	45	6	int:FEV
Interaction	ELF1 interactions	KMT2A ATF1 TAF6 MGA EMSY	8.82e-06	126	45	5	int:ELF1
Interaction	CA2 interactions	KMT2A HUWE1 USP42 PCNA	2.23e-05	74	45	4	int:CA2
Cytoband	7q22	MUC3B ZAN MUC3A	8.82e-06	38	48	3	7q22
Cytoband	Ensembl 112 genes in cytogenetic band chr7q22	TAF6 ZAN MUC17 MUC3A	8.31e-05	219	48	4	chr7q22
GeneFamily	CD molecules\|Mucins	MUC19 MUC16 MUC5B MUC3B MUC22 MUC17 MUC3A MUC4	5.59e-18	21	31	8	648
GeneFamily	T-boxes	TBX3 MGA	4.28e-04	18	31	2	766
Coexpression	NABA_ECM_AFFILIATED	MUC19 OPRPN MUC16 MUC5B MUC22 MUC17 MUC3A MUC4	6.73e-10	170	47	8	M5880
Coexpression	NABA_MATRISOME_ASSOCIATED	MUC19 OPRPN MUC16 MUC5B NRG3 MUC22 MUC17 MUC3A MUC4	6.37e-06	751	47	9	M5885
Coexpression	NABA_ECM_AFFILIATED	MUC19 MUC16 MUC5B MUC17 MUC4	9.34e-06	158	47	5	MM17063
Coexpression	NABA_MATRISOME	MUC19 OPRPN MUC16 MUC5B NRG3 MUC22 MUC17 MUC3A MUC4	7.43e-05	1026	47	9	M5889
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_7DY_UP	SCYL2 TRAK2 TMEM123 MAP3K1	7.98e-05	127	47	4	M40905
Coexpression	BROWNE_HCMV_INFECTION_8HR_DN	NAV3 SPN LRP8	8.83e-05	48	47	3	M7846
ToppCell	nucseq-Epithelial-Epithelial_Glandular\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC16 MUC5B MUC17 MUC3A MUC4 MGAM2	3.42e-08	179	47	6	859cd8ee414ad6207c046ada2e655e49322dd01c
ToppCell	nucseq-Epithelial-Epithelial_Glandular-Goblet\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC16 MUC5B MUC17 MUC3A MUC4 MGAM2	3.53e-08	180	47	6	3dc80bc636bf0e6ffc9762853132a9fe59fd1f66
ToppCell	nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC16 MUC5B MUC17 MUC3A MUC4 MGAM2	3.53e-08	180	47	6	668a2d8e1d5a390309d5eb62c836f5903144bea9
ToppCell	Control-Epithelial_cells-Airway_mucous\|Control / group, cell type (main and fine annotations)	MUC16 MUC5B MUC17 MUC3A MUC4 MGAM2	3.90e-08	183	47	6	15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2
ToppCell	Control-Epithelial_cells-Airway_goblet\|Control / group, cell type (main and fine annotations)	MUC16 MUC5B MUC17 MUC3A MUC4 MGAM2	4.03e-08	184	47	6	d92a71441e4e19f8c301999d8186f8e48e3cd162
ToppCell	COVID-19-kidney-Glomerular_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TBX3 NRG3 AJAP1 ADGRL2 MTSS1	1.87e-06	194	47	5	660535b492445063d965095a50e1e299ce04c50a
ToppCell	droplet-Lung-LUNG-30m-Myeloid-Neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MUC5B MUC4 VASP STON2	2.56e-05	162	47	4	dddf7a3901ae59e3494d8a6740db0fa15cc96d47
ToppCell	droplet-Lung-LUNG-30m-Myeloid-neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MUC5B MUC4 VASP STON2	2.56e-05	162	47	4	2a4e09545e9874519f0f56e81065104987d81cd6
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231\|Adult / Lineage, Cell type, age group and donor	TBX3 NRG3 AJAP1 ADGRL2	2.88e-05	167	47	4	5af9127bae05768a5164d5708a4ad37edca99324
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TBX3 NRG3 ADGRL2 MTSS1	3.02e-05	169	47	4	987ff79ad563825dd9877ea8ccb536758f8c6700
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122\|Adult / Lineage, Cell type, age group and donor	TBX3 NRG3 AJAP1 ADGRL2	3.16e-05	171	47	4	bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TBX3 NRG3 ADGRL2 MTSS1	3.31e-05	173	47	4	f193c63cc536d891c9d23043765e320252bb6e65
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 MUC3A MUC4 LRP8	3.39e-05	174	47	4	207aa0118633cbe9a65839bbb1bb3ba9f8118ad2
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.4.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TSHZ3 MUC5B CCNB3 CD300A	3.39e-05	174	47	4	b6e3fa995def40a8fbdfc249fe108c303931a171
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MUC19 POM121L2 NRG3 ADGRL2	3.78e-05	179	47	4	d3438fed0d85d5ed5afa8ff820c45143d77b6c0d
ToppCell	Control-Endothelial_cells-Capillary_endothelial_cells\|Control / group, cell type (main and fine annotations)	TBX3 NRG3 AJAP1 ADGRL2	3.86e-05	180	47	4	b043f9ffb9a4cd427a15bebb86a711c7b08866e8
ToppCell	Ciliated_cells-A-Donor_07\|World / lung cells shred on cell class, cell subclass, sample id	MUC16 MUC5B MUC4 OMG	3.86e-05	180	47	4	d9be152773fe9f2160edad9246fa03c03afeafd6
ToppCell	COVID-19-Endothelial_cells-Capillary_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	TBX3 NRG3 AJAP1 ADGRL2	3.95e-05	181	47	4	c5f9c92af1384d9089c65afdf41c6feb8345a3ae
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D175\|Adult / Lineage, Cell type, age group and donor	TBX3 NRG3 AJAP1 ADGRL2	4.03e-05	182	47	4	8b4a07ebd7a133a33ef333cfa29d12c4f3d4d9ac
ToppCell	Ciliated_cells-A-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	MUC16 MUC5B MUC4 OMG	4.21e-05	184	47	4	07c5a9633ccdcd18771e3230d6198a55c400afa6
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D231\|Adult / Lineage, Cell type, age group and donor	NAV3 TBX3 NRG3 ADGRL2	4.30e-05	185	47	4	07f9f38f0739d7c830641723a38385550ac1ac92
ToppCell	Adult-Immune-interstitial_macrophage_(C1Q_positive)-D175\|Adult / Lineage, Cell type, age group and donor	TSHZ3 MAP3K1 MTSS1 STON2	4.30e-05	185	47	4	ab5704b96f1d368911308797d10c7c52766ab134
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|Adult / Lineage, Cell type, age group and donor	TBX3 NRG3 AJAP1 ADGRL2	4.58e-05	188	47	4	e5cad03f4a64147fe8174e7f614cf45233ffb9b7
ToppCell	systemic_lupus_erythematosus-flare-Myeloid-non-classical_monocyte-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SPN VASP CD300A MTSS1	4.58e-05	188	47	4	3e94d105ca96ceb5fdcca39a8050217913bc02da
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Lymphocytic\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	MLH1 ATF1 TAF6 NPAP1	4.77e-05	190	47	4	373629dde5eda722424c5e6087763f0c5db67cf4
ToppCell	ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	OMG MAP3K1 MTSS1 STON2	4.77e-05	190	47	4	9ce301841ce9486701fa28eb2a9929e35d476878
ToppCell	facs-Marrow-B-cells-18m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SCPEP1 TMEM123 MAP3K1 MTSS1	4.87e-05	191	47	4	10644258b97f9c99eb0e199b64b970f6b986aa41
ToppCell	facs-Marrow-B-cells-18m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SCPEP1 TMEM123 MAP3K1 MTSS1	4.87e-05	191	47	4	408942fc8db939239aeee6ae07a21362133c9e2e
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM123 MED13 MAP3K1 MTSS1	4.97e-05	192	47	4	2de242d81dc085ae734eb7d1f091af9a542e0866
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM123 MED13 MAP3K1 MTSS1	4.97e-05	192	47	4	ba2a683472a8b785dbf666dc6e94356d879486c3
ToppCell	normal-na-Myeloid-non-classical_monocyte-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	SPN VASP CD300A MTSS1	5.07e-05	193	47	4	053adc7ed9f997b503e12239a684bb9f5896e10c
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	HUWE1 MGA HECTD1 MED13	5.07e-05	193	47	4	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NAV3 TBX3 NRG3 ADGRL2	5.07e-05	193	47	4	ad3f4fcc8e2816d696cbcde744dc16500e51ccac
ToppCell	facs-Marrow-B-cells-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM123 MED13 MAP3K1 MTSS1	5.07e-05	193	47	4	24c34c6635eb7fc2878282803c421b64320e77d8
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM123 MED13 MAP3K1 MTSS1	5.17e-05	194	47	4	7ee8ac172c2dee7df7dc4eb222e0985a0089bda8
ToppCell	COPD-Endothelial-VE_Capillary_B\|COPD / Disease state, Lineage and Cell class	NAV3 TBX3 NRG3 ADGRL2	5.17e-05	194	47	4	18b7f901c12ca4f21f9a1eafd092aefe4d668b6d
ToppCell	BLOOD--(3)_MNP-(3)_Non_classical_monocytes\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	SPN VASP CD300A MTSS1	5.17e-05	194	47	4	f80433c7dd7590ca8c49630d2cd018b63438fd92
ToppCell	myeloid-CD16+_Monocyte\|myeloid / Lineage and Cell class	SPN VASP CD300A MTSS1	5.17e-05	194	47	4	aeeadfeb01827dbc7de6576c76fb2e41a3c59247
ToppCell	COPD-Endothelial-VE_Capillary_B\|World / Disease state, Lineage and Cell class	NAV3 TBX3 NRG3 ADGRL2	5.17e-05	194	47	4	68705a6eca947c5b42b943d5224a7aef2a744007
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM123 MED13 MAP3K1 MTSS1	5.27e-05	195	47	4	d77423d0ec64b397c6d1eec181c5fc0acaa92d63
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MUC19 MUC16 MUC3A VASP	5.27e-05	195	47	4	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	IIF-Myeloid-CD16_Mono\|IIF / Disease, Lineage and Cell Type	SPN VASP CD300A MTSS1	5.27e-05	195	47	4	87c1f52ab19b105bae3f315496c620c226a77a7f
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM123 MED13 MAP3K1 MTSS1	5.27e-05	195	47	4	f5bf4797972185afa76638293166abd536e5472f
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MUC19 MUC16 MUC3A VASP	5.27e-05	195	47	4	19853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCell	Control-Non-classical_Monocyte-\|Control / Disease condition and Cell class	SPN VASP CD300A MTSS1	5.38e-05	196	47	4	b17ab094cdc7050c2997e24ed474779b5d6f6146
ToppCell	15-Trachea\|15 / Age, Tissue, Lineage and Cell class	MUC16 MUC5B MUC4 OMG	5.38e-05	196	47	4	fd17403422cf95c24f6be1c2d78764bb352f7f2e
ToppCell	COVID-19-lung-Capillary_Aerocytes\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TBX3 NRG3 AJAP1 ADGRL2	5.38e-05	196	47	4	49cc0a2b9739abad61dff7292ea0b14d28ff35c4
ToppCell	Control-Non-classical_Monocyte\|Control / Disease condition and Cell class	SPN VASP CD300A MTSS1	5.38e-05	196	47	4	404064ccfe2cb73df7a7f88aa65d86b97dcef9d4
ToppCell	COVID-19-lung-Capillary_Aerocytes\|lung / Disease (COVID-19 only), tissue and cell type	TBX3 NRG3 AJAP1 ADGRL2	5.38e-05	196	47	4	4ac4073380d939a73cec7413e9f3f5ef616d2924
ToppCell	systemic_lupus_erythematosus-treated-Myeloid-non-classical_monocyte\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SPN VASP CD300A MTSS1	5.49e-05	197	47	4	1a82e0e74fc5fd71c490d98e8813d719b0b81aa6
ToppCell	URO-Myeloid-CD16_Mono\|URO / Disease, Lineage and Cell Type	SPN VASP CD300A MTSS1	5.49e-05	197	47	4	0201ba77419487e75edd5ea07ad7e5cbe87757d4
ToppCell	systemic_lupus_erythematosus-flare-Myeloid-non-classical_monocyte-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SPN VASP CD300A MTSS1	5.49e-05	197	47	4	1463522df1b6358cbe3b5022a3e153878e9c9e43
ToppCell	systemic_lupus_erythematosus-treated-Myeloid-non-classical_monocyte-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SPN VASP CD300A MTSS1	5.49e-05	197	47	4	46d8c7e9b3aff70bc58894282d0ec9e87d37235f
ToppCell	normal-na-Myeloid-non-classical_monocyte-female\|normal / PBMC cell types (v2) per disease, treatment status, and sex	SPN VASP CD300A MTSS1	5.60e-05	198	47	4	d91bd26e499637949768587603cad3c03dcc56e7
ToppCell	ICU-SEP-Myeloid-CD16_Mono\|ICU-SEP / Disease, Lineage and Cell Type	SPN VASP CD300A MTSS1	5.60e-05	198	47	4	3e6f262ec71e99a5dadbaaeaff1b4f1894907c7d
ToppCell	systemic_lupus_erythematosus-managed-Myeloid-non-classical_monocyte-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SPN VASP CD300A MTSS1	5.60e-05	198	47	4	ad8d4ad042f06fd1afbaef903fb36e57e4d23a7c
ToppCell	systemic_lupus_erythematosus-flare-Myeloid-non-classical_monocyte\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SPN VASP CD300A MTSS1	5.60e-05	198	47	4	11b0d021114df73a539b04f76dd7c63f1fdbdf4f
ToppCell	systemic_lupus_erythematosus-managed-Myeloid-non-classical_monocyte-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SPN VASP CD300A MTSS1	5.60e-05	198	47	4	8de49c62ab533031936db4cee50ff13b259ecc22
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TBX3 NRG3 ADGRL2 MTSS1	5.60e-05	198	47	4	92416e65a0dc1a4bf931833407620ea05d362f56
ToppCell	normal-na-Myeloid-non-classical_monocyte\|normal / PBMC cell types (v2) per disease, treatment status, and sex	SPN VASP CD300A MTSS1	5.60e-05	198	47	4	f5a12861e2b8ff8309f3e4d0ad83d4f6860cc616
ToppCell	systemic_lupus_erythematosus-managed-Myeloid-non-classical_monocyte\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SPN VASP CD300A MTSS1	5.60e-05	198	47	4	60e5bd8dfe27c43ce5f4da19b65270c41577ef4f
ToppCell	COVID-19_Convalescent-Non-classical_Monocyte-\|COVID-19_Convalescent / Disease condition and Cell class	SPN VASP CD300A MTSS1	5.71e-05	199	47	4	996a207b8b91e10dd018dc07aaf5ecd473bfeaad
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW13-Stem_cells\|GW13 / Sample Type, Dataset, Time_group, and Cell type.	NCOA2 MLH1 NBAS PCNA	5.71e-05	199	47	4	fd1d1b95e01719e3d0a17d9d1f29717a47209d32
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TBX3 NRG3 AJAP1 ADGRL2	5.71e-05	199	47	4	dc88ce36cc066eb6c28cfd5b9b60fe07f8cc7b53
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW13-Stem_cells-Stem_cells\|GW13 / Sample Type, Dataset, Time_group, and Cell type.	NCOA2 MLH1 NBAS PCNA	5.71e-05	199	47	4	91882af9dc7265c9b419f4415cbcf656087a2ab3
ToppCell	COVID-19_Convalescent-Non-classical_Monocyte\|COVID-19_Convalescent / Disease condition and Cell class	SPN VASP CD300A MTSS1	5.71e-05	199	47	4	c9250c80dd5bc3d27c6065b99119ff7dcf392e84
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells\|GW13 / Sample Type, Dataset, Time_group, and Cell type.	NCOA2 MLH1 NBAS PCNA	5.82e-05	200	47	4	d933978b55fefe52cad599b36f6b47a0c7f71f96
ToppCell	Leuk-UTI-Myeloid-CD16_Mono\|Leuk-UTI / Disease, Lineage and Cell Type	SCPEP1 VASP CD300A MTSS1	5.82e-05	200	47	4	ea5cd46031c7e8604387be2a82a1d59022458632
ToppCell	Tracheal-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD16\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SPN CD300A MAP3K1 MTSS1	5.82e-05	200	47	4	5ea3e74687893b8ca6cb915f0f14a14d4692775c
ToppCell	Lung_Parenchyma-Severe\|Lung_Parenchyma / Location, Disease Group, Cell group, Cell class (2021.03.09)	MUC16 MUC5B MUC4 OMG	5.82e-05	200	47	4	62502bb23ca732daed32c838ce9719093f3aaeb0
ToppCell	MS-IIF-Myeloid-CD16+_Monocyte\|IIF / Disease, condition lineage and cell class	SPN VASP CD300A MTSS1	5.82e-05	200	47	4	c6245c24a5e7c550d06a3b2f180773638f9f3a4a
ToppCell	Sepsis-ICU-SEP-Myeloid-CD16+_Monocyte\|ICU-SEP / Disease, condition lineage and cell class	SPN VASP CD300A MTSS1	5.82e-05	200	47	4	de39d94af8ef489ea347b6ecf1a39e7849f2f72e
ToppCell	NS-control\|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MUC16 SCPEP1 HECTD1 MUC4	5.82e-05	200	47	4	ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCell	Sepsis-URO-Myeloid-CD16+_Monocyte\|URO / Disease, condition lineage and cell class	SPN VASP CD300A MTSS1	5.82e-05	200	47	4	82408dac860899510a1f5849d2b0b1692053fb96
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TBX3 NRG3 AJAP1 ADGRL2	5.82e-05	200	47	4	105c67e4f5eff036013d655c8e8ac577d32dae2e
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells-Neuroepithelial_cell\|GW13 / Sample Type, Dataset, Time_group, and Cell type.	NCOA2 MLH1 NBAS PCNA	5.82e-05	200	47	4	3d932765c31aef1f80a118d51e8e66c50a758dbb
ToppCell	Sepsis-Leuk-UTI-Myeloid-CD16+_Monocyte\|Leuk-UTI / Disease, condition lineage and cell class	SCPEP1 VASP CD300A MTSS1	5.82e-05	200	47	4	f4abe8b693db9e3d955b2529a8f848cb0459e900
ToppCell	Posterior_cortex-Macroglia-OLIGODENDROCYTE-O2-Tfr-Oligodendrocyte.Tfr.Sez6_(Sez6)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	ZAN MUC4 STON2	7.12e-05	76	47	3	2b1d7bafad3d9a01fc47790418160950330576c5
ToppCell	Posterior_cortex-Macroglia-OLIGODENDROCYTE-O2-Tfr-Oligodendrocyte.Tfr.Sez6_(Sez6)-\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	ZAN MUC4 STON2	7.12e-05	76	47	3	322c3a4c3abdc419f162861ecd52c0ad6ef2381c
ToppCell	Myeloid-Myeloid-C_(Cd16+_Monocyte)\|Myeloid / shred on cell class and cell subclass (v4)	NCOA2 SPN CD300A	2.56e-04	117	47	3	d1936e76a935216783a73ab414e4147fa48e68eb
ToppCell	NS-moderate-d_07-13-Epithelial-unknown_epithelial\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MUC16 MUC4 STON2	3.48e-04	130	47	3	1491e8975520e99c527a5b5bee64875d124f7bf4
ToppCell	343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	TBX3 AJAP1 ADGRL2	4.24e-04	139	47	3	2fdc8f36510aff24abbc79ef2a842db75a85f946
ToppCell	343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	TBX3 AJAP1 ADGRL2	4.24e-04	139	47	3	5970a654c64e3b54f9d18c102f5b125eec892fc5
ToppCell	NS-critical-d_07-13-Epithelial-unknown_epithelial\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MUC16 DSC1 MUC4	4.42e-04	141	47	3	33ad925ff7be3c682741a6328216a89f9d4033e9
ToppCell	facs-Marrow-B-cells-24m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HAVCR1 DSC1 LRP8	4.60e-04	143	47	3	6df16bf0324661cd9707df69cb39f4b5498d6d49
ToppCell	facs-Marrow-B-cells-24m-Myeloid-CD4+_macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HAVCR1 DSC1 LRP8	4.99e-04	147	47	3	9d7e965fe61bd7b31e09c4b2129a5a98c36f4811
ToppCell	facs-Marrow-B-cells-24m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HAVCR1 DSC1 LRP8	4.99e-04	147	47	3	38552953ff65a0fc20bee6ef57dc5885306ad18b
ToppCell	pdx-Tumor_cells-T4\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	MUC16 DSC1 MUC4	5.50e-04	152	47	3	7ccc56b79c499dd48dab8e2d936edca5223b9356
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MUC16 HAVCR1 NRG3	5.60e-04	153	47	3	499670e716fc85ce76630fc813cec86f8419f2a1
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SPN PCNA LRP8	5.60e-04	153	47	3	0ad401cb70b9edfc6ae6ccba6879c6c2b6c4d296
ToppCell	droplet-Fat-SCAT-30m-Myeloid-monocyte\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MLH1 SPN CD300A	5.60e-04	153	47	3	2731c3d4ac40ecc22108f8f3f45a069077159125
ToppCell	(6)_Endothelial_cells-(6)_Endothelial-C_(Capillary_Aerocyte_)\|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	TBX3 AJAP1 ADGRL2	6.04e-04	157	47	3	84f629b7f589ca8a1abc220fa740c4a6fdc1b579
ToppCell	facs-Marrow-KLS-24m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSHZ3 SPN STON2	6.04e-04	157	47	3	662d5026e0e4249029fc6f3abc771d775d7bc3bb
ToppCell	facs-Marrow-KLS-24m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSHZ3 SPN STON2	6.04e-04	157	47	3	3c6be6995c00c4cadbd209c66bf9a87c8c238652
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_B\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	SPN OMG MTSS1	6.15e-04	158	47	3	1bf692f1e85f677cd62805437b7a59cfaf3b0449
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 MUC5B MUC4	6.27e-04	159	47	3	60b1f4dce2ce0911160fda17f137c064da31e2eb
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_macrophage-microglial_cell\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	NAV3 OPRPN MUC22	6.27e-04	159	47	3	31ec8222c766cb614e1cf27f74ee9d99489eca5c
ToppCell	facs-Liver-Non-hepatocytes-3m-Myeloid-myeloid_leukocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HAVCR1 CD300A LRP8	6.38e-04	160	47	3	237430af14830b38e58da8a4224036e5c6b71c5b
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MUC16 MUC5B MUC4	6.50e-04	161	47	3	2d63b279d9a5132e1c09b03930bf9039036d24a2
ToppCell	droplet-Lung-30m-Hematologic-myeloid-neutrophil\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MUC5B MUC4 VASP	6.61e-04	162	47	3	9c9a63adb692651ea5a52cc77b02c5ce11d0ccea
Drug	cellobiitol	MUC3B SPN MUC3A MUC4	9.17e-07	37	46	4	CID000003871
Drug	Tn epitope	MUC3B SPN MUC3A MUC4	4.61e-06	55	46	4	CID000447272
Drug	geldanamycin	SCYL2 NCOA2 KMT2A NBAS HECTD1 MED13 MAP3K1	8.93e-06	371	46	7	ctd:C001277
Drug	mucic acid	HAVCR1 MUC3B SPN MUC3A	3.00e-05	88	46	4	CID000000607
Drug	rioprostil	MUC3B SPN MUC3A	3.67e-05	32	46	3	CID005311413
Drug	(-) -Levobunolol hydrochloride [27912-14-7]; Down 200; 12.2uM; MCF7; HT_HG-U133A	NCOA2 OPRPN POM121L2 TBX3 VASP	4.40e-05	194	46	5	4134_DN
Drug	Lasalocid sodium salt [25999-20-6]; Up 200; 6.6uM; MCF7; HT_HG-U133A	POM121L2 TBX3 MUC5B AJAP1 MAP3K1	4.62e-05	196	46	5	3360_UP
Drug	Alcuronium chloride [15180-03-7]; Down 200; 5.4uM; MCF7; HT_HG-U133A	NCOA2 MUC5B AJAP1 SPN MAP3K1	4.62e-05	196	46	5	4409_DN
Drug	Primidone [125-33-7]; Down 200; 18.4uM; HL60; HT_HG-U133A	POM121L2 HUWE1 SPN OMG MTSS1	4.74e-05	197	46	5	3065_DN
Drug	Medrysone [2668-66-8]; Up 200; 11.6uM; MCF7; HT_HG-U133A	HUWE1 SPN MUC4 OMG CD300A	4.97e-05	199	46	5	3603_UP
Disease	cholangiocarcinoma (is_marker_for)	MUC16 MUC5B MUC3A MUC4	3.35e-06	64	47	4	DOID:4947 (is_marker_for)
Disease	mucositis (biomarker_via_orthology)	MUC4 PCNA	2.48e-05	5	47	2	DOID:0080178 (biomarker_via_orthology)
Disease	Prostatic Neoplasms	NCOA2 MLH1 KMT2A TBX3 MGA MUC4 MAP3K1	5.09e-05	616	47	7	C0033578
Disease	Malignant neoplasm of prostate	NCOA2 MLH1 KMT2A TBX3 MGA MUC4 MAP3K1	5.09e-05	616	47	7	C0376358
Disease	cocaine use disorder, social environment measurement	TRAK2 ADGRL2	6.91e-05	8	47	2	EFO_0010445, EFO_0010552
Disease	otitis media (is_marker_for)	MUC5B MUC4	1.11e-04	10	47	2	DOID:10754 (is_marker_for)
Disease	Malignant neoplasm of stomach	MLH1 KMT2A NBAS TBX3 MTSS1	1.14e-04	300	47	5	C0024623
Disease	pancreatic ductal carcinoma (is_marker_for)	MUC5B MUC3A MUC4	1.28e-04	61	47	3	DOID:3587 (is_marker_for)
Disease	malignant pleural mesothelioma (is_marker_for)	NCOA2 MLH1	2.23e-04	14	47	2	DOID:7474 (is_marker_for)
Disease	colorectal cancer	MLH1 SCPEP1 TBX3 ATF1 NRG3 MUC22	3.78e-04	604	47	6	MONDO_0005575
Disease	systemising measurement	NBAS TSHZ3	5.12e-04	21	47	2	EFO_0010221
Disease	Sjogren's syndrome (is_marker_for)	MUC19 MUC16	6.70e-04	24	47	2	DOID:12894 (is_marker_for)
Disease	RS-10-hydroxywarfarin to RS-warfarin ratio measurement	SCPEP1 MUC3B MUC3A	7.25e-04	110	47	3	EFO_0803335
Disease	breast cancer, lung cancer	POM121L2 MAP3K1	7.28e-04	25	47	2	MONDO_0007254, MONDO_0008903
Disease	Hyalinosis, Segmental Glomerular	HAVCR1 PCNA	9.14e-04	28	47	2	C0086432
Disease	stimulant use measurement	NCOA2 NBAS	9.14e-04	28	47	2	EFO_0600076
Disease	eicosapentaenoic acid measurement	TSHZ3 MUC22	1.12e-03	31	47	2	EFO_0007760
Disease	renal cell carcinoma (is_marker_for)	MLH1 HAVCR1 PCNA	1.12e-03	128	47	3	DOID:4450 (is_marker_for)
Disease	Hereditary Diffuse Gastric Cancer	KMT2A NBAS TBX3 MTSS1	1.21e-03	293	47	4	C1708349
Disease	Stomach Neoplasms	KMT2A NBAS TBX3 MTSS1	1.28e-03	297	47	4	C0038356
Disease	diet measurement	SCYL2 NBAS POM121L2 NRG3 ADGRL2 MUC17 STON2	1.28e-03	1049	47	7	EFO_0008111
Disease	glomerular filtration rate, renal transplant outcome measurement	NBAS ADGRL2	1.43e-03	35	47	2	EFO_0005199, EFO_0005208
Disease	anti-GAD65 autoimmune neurological syndromes	ZAN MUC22	1.43e-03	35	47	2	EFO_0803379
Disease	Focal glomerulosclerosis	HAVCR1 PCNA	1.51e-03	36	47	2	C0017668
Disease	stomach cancer (is_marker_for)	NCOA2 TBX3 PCNA	1.52e-03	142	47	3	DOID:10534 (is_marker_for)
Disease	diabetic nephropathy	NAV3 ADGRL2 LRP8	1.77e-03	150	47	3	EFO_0000401
Disease	colorectal cancer, colorectal adenoma	TBX3 ATF1 MUC22	1.84e-03	152	47	3	EFO_0005406, MONDO_0005575
Disease	heart rate response to exercise	MUC3B MUC3A	2.15e-03	43	47	2	EFO_0009184
Disease	Proteinuria	MUC16 HAVCR1	2.15e-03	43	47	2	C0033687
Disease	esophagus squamous cell carcinoma (is_implicated_in)	MLH1 MAP3K1	2.35e-03	45	47	2	DOID:3748 (is_implicated_in)
Disease	multiple sclerosis symptom measurement	NCOA2 MTSS1	2.46e-03	46	47	2	EFO_0803536
Disease	primary ovarian insufficiency (implicated_via_orthology)	MLH1 USP42	2.46e-03	46	47	2	DOID:5426 (implicated_via_orthology)
Disease	serum gamma-glutamyl transferase measurement	MLH1 KMT2A ADGRL2 OMG MED13 EMSY	3.16e-03	914	47	6	EFO_0004532
Disease	amino acid measurement	NAV3 NBAS NRG3 ADGRL2 MGAM2	4.37e-03	678	47	5	EFO_0005134

Protein segments in the cluster

Peptide	Gene	Start	Entry
VAATTTTTTTATPMT	AJAP1	216	Q9UKB5
TTTTTATPMTLQTKG	AJAP1	221	Q9UKB5
TIISTTSTTSQKGPM	ADGRL2	416	O95490
SSIATMTSVGKSRTT	CCNB3	1071	Q8WWL7
TTTTTTVATGSMATP	MUC5B	2106	Q9HC84
TKATTTRATSSMSTP	MUC5B	3111	Q9HC84
TTTTTVATGSMATPS	MUC5B	3921	Q9HC84
FPKAMETTTTTTSTT	NRG3	121	P56975
STSATSLSATVMVSK	MUC16	986	Q8WXI7
TSIASSTMDVTKTAS	MUC16	2376	Q8WXI7
STMDVTKTASISPTS	MUC16	2381	Q8WXI7
TKTASISPTSISGMT	MUC16	2386	Q8WXI7
TITTMGTNSISTTTP	MUC16	3541	Q8WXI7
SPVSMSSVLTSSLVK	MUC16	4771	Q8WXI7
TTVSTSMSVSSETTK	MUC16	6926	Q8WXI7
STSPIKTESTEMTIT	MUC16	9066	Q8WXI7
TSMMTSEKITVTTST	MUC4	256	Q99102
TTRSVSPMTDTKTVT	MUC4	651	Q99102
TTMPSPTSSTTVSTI	MGAM2	2081	Q2M2H8
ATVTTTSTKDNTMSP	MGAM2	2356	Q2M2H8
VTAAASSSMVTTPTS	MGA	1701	Q8IWI9
TSEPLSSKMYTTSIT	SPN	36	P16150
TTVPETTMASSTTST	MUC22	146	E2RYF6
TKATPLSSTVTLSMS	PCNA	216	P12004
SSPSTTMSRKSSVCS	MTSS1	261	O43312
ASGMTGVTTTTKTTT	MUC19	7096	Q7Z5P9
TFTVSSSSAMSTSVI	MUC3A	471	Q02505
APTTTTSFTTSTTME	MUC3A	571	Q02505
STSMISSTVSTGIPT	MUC3A	806	Q02505
VTSTTMTPSSLSTDT	MUC3A	1181	Q02505
VSSSSAMSTSVIPSS	MUC3A	1226	Q02505
ITSVPTTLGTMVTST	MUC3A	1546	Q02505
TMLTVKQSSTATSPT	NAV3	346	Q8IVL0
TTTVSISPTTKGSKS	HUWE1	3541	Q7Z6Z7
TATTMKVLSNTTTTT	NBAS	1411	A2RRP1
SSNTTVTTMKPTAAS	TMEM123	81	Q8N131
NMTSTTLKSTPKTTS	TMEM123	106	Q8N131
TPGTTSTVTMSTSSV	HECTD1	1601	Q9ULT8
ASSQTPTMCTTTVTV	DSC1	446	Q08554
KIQLTSSVSSTPSVM	KMT2A	3101	Q03164
SGTTTKITTIPMTSK	EMSY	561	Q7Z589
TSTTTLASTMTRTVP	LRP8	741	Q14114
MPVSTTVVASSAIST	MUC17	2166	Q685J3
MPVSTTTVASSETST	MUC17	3286	Q685J3
TMTTRTKPSTRTTSF	MUC17	4091	Q685J3
STNTVTSMTTTTSRP	MUC3B	266	Q9H195
TSMTTTTSRPTATNT	MUC3B	271	Q9H195
SSLVGTTSPTMSTVR	MUC3B	451	Q9H195
STTTTTTTTEQPKPM	MAP3K1	941	Q13233
TKFIVMSSSSSAPST	TAF6	536	P49848
SSTLSSSSMSLSPKL	TBX3	696	O15119
NILTKSTPTSTMESS	SCPEP1	271	Q9HB40
SIPTTTTVLTTMTVS	HAVCR1	171	Q96D42
TMTVSTTTSVPTTTS	HAVCR1	181	Q96D42
NMSSLTSLSVSTPKS	SCYL2	726	Q6P3W7
ATATTSTSTKPTMTI	OPRPN	161	Q99935
STSTKPTMTISSSTV	OPRPN	166	Q99935
SSTMTVTSGVAISTS	MED13	1511	Q9UHV7
SGEMVKSTTSLTSSS	MLH1	356	P40692
SVITSKPMNSTSVIS	NPAP1	541	Q9NZP6
MVTNTSLTSSTKSSP	OMG	361	P23515
SVVMSTTLASTSKDS	POM121L2	621	Q96KW2
SMPTTSASKASVRSI	STON2	836	Q8WXE9
MTSPVTLTSQTTKTD	ATF1	196	P18846
MTPASITAAKTSTIT	CD300A	131	Q9UGN4
ISMTSVTSVPTSGLS	NCOA2	1411	Q15596
STTTFSSTMSLAKLL	TRAK2	731	O60296
TSNASTMSVSSKVTK	USP42	566	Q9H9J4
VMSPSSSKSTKSTST	SRRM5	56	B3KS81
TVTTAKTSAVVSFMS	TSHZ3	821	Q63HK5
TLPRMKSSSSVTTSE	VASP	316	P50552
MTSVILGTTTTSRSS	ZAN	1026	Q9Y493